Important Notice

Jump to section

• Overview & contents
• i. Important Notice
• 1. Executive Summary
• 2. A Note on the Name
• 3. The Market and the FMD Crisis
• 4. Foot-and-Mouth Disease as a Business Risk
• 5. The Production System
• 6. Herd Performance
• 7. SWOT and Competitive Position
• 8. Grazing, Land and Water
• 9. Unit Economics
• 10. Route to Market
• 11. The Five-Year Build and Its Gates
• 12. Funding
• 13. People, Security and Stock Theft
• 14. Compliance and Traceability
• 15. Financial Projections
• 16. Break-Even
• 17. Sensitivity and Scenarios
• 18. Risk Management
• 19. Implementation Timeline
• 20. Returns
• 21. Key Performance Indicators
• 22. Key Assumptions
• 23. Conclusion
• A. Appendix A: Consolidated Financial Summary
• B. Appendix B: Capital Schedules
• C. Appendix C: Funding and Debt Schedules
• D. Appendix D: Risk Register
• E. Appendix E: Glossary

This business plan has been prepared for Cattle Baron Master, a cow-calf weaner production enterprise proposed for South Africa, in support of R2.20 million of founder equity and R3.40 million of grant funding targeted through the Blended Finance Scheme.

Basis of the figures. Every figure derives from a single model driven by breeding cows, calving and weaning percentages, weaner weight and the blended weaner price. The income statement, balance sheet and cash flow statement are fully articulated: the balance sheet is derived rather than plugged and balances to the rand in every year, owner’s funds roll forward from contributed capital and grants received plus retained earnings, and the closing cash position reconciles exactly to the cash flow statement.

Cash and non-cash earnings. Reported EBITDA includes the annual increase in the value of the breeding herd, which is real value but stands in a camp rather than in the bank. Year 5 EBITDA of R2.52 million includes R2.41 million of herd growth; cash EBITDA is R112 000. Every table in this plan shows both, because confusing them is how cattle enterprises run out of money while their herd is growing.

Capital. The R11.20 million deployed comprises R8.11 million of infrastructure and equipment, R2.48 million of foundation herd and breeding bulls, and R1.21 million of working capital. Only the infrastructure element is depreciated; the herd is carried as a biological asset and revalued through the herd growth line. The working capital element funds opening trading rather than fixed investment.

Taxation. South African corporate income tax is applied at 27 per cent on taxable profit, with assessed losses carried forward subject to the section 20 limitation. On that basis no tax is payable within the five-year forecast and R247 000 of assessed loss remains unutilised.

Market and disease data. Price, outbreak, vaccination and policy statistics in Sections 3 and 4 are drawn from published market reporting, Department of Agriculture announcements and parliamentary material current to August 2026. The disease position changes rapidly and should be re-checked with the state veterinary service before any purchase or movement decision.

Grant dependency. R3.40 million of the programme is targeted from the Blended Finance Scheme. In June 2026 Parliament’s Portfolio Committee on Agriculture reported that the scheme requires roughly R1.5 billion a year but was allocated only R613 million for 2026/27, and that Land Bank had over-committed available funds. Section 11 sets out the position and Section 16 models the alternative.

Confidentiality. This document is delivered in confidence to the named recipient. It may not be reproduced or circulated in whole or in part without prior written consent.

Contents

1. Executive Summary 4

2. A Note on the Name 7

3. The Market and the FMD Crisis 8

4. Foot-and-Mouth Disease as a Business Risk 10

5. The Production System 13

6. Herd Performance 14

7. SWOT and Competitive Position 16

8. Grazing, Land and Water 18

9. Unit Economics 20

10 Route to Market 22

11 The Five-Year Build and Its Gates 23

12 Funding 24

13 People, Security and Stock Theft 28

14 Compliance and Traceability 30

15 Financial Projections 31

16 Break-Even 37

17 Sensitivity and Scenarios 39

18 Risk Management 42

19 Implementation Timeline 44

20 Returns 46

21 Key Performance Indicators 48

22 Key Assumptions 49

23 Conclusion 51

A. Appendix A — Consolidated Financial Summary 52

B. Appendix B — Capital Schedules 53

C. Appendix C — Funding and Debt Schedules 56

D. Appendix D — Risk Register 58

E. Appendix E — Glossary 60